BGHBX Fees and Costs — Baillie Gifford Health Innovation Equities Fund, Institutional Class
Data updated: 2025-03-10
The net expense ratio is 0.75%: a 0.50% management fee plus 1.16% other expenses, less a 0.91% fee waiver. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $5K in broker commissions, 0.0422% of average net assets, and portfolio turnover was 23%.
BGHBX Fees and Expenses
Annual operating expenses and sales charges of BGHBX. Prospectus, as of April 30, 2024.
| Annual operating expenses | |
|---|---|
| Management fee | 0.50% |
| 12b-1 fee | 0.00% |
| Other expenses | 1.16% |
| Gross expense ratio | 1.66% |
| Fee waiver | −0.91% |
| Net expense ratio | 0.75% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
BGHBX Costs Over Time
On $10,000 invested in BGHBX, assuming 5% a year before costs, total costs come to $498 over 5 years, cutting the return by 0.83% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.75%) | $79 | $246 | $428 |
| Trading costs (broker commissions) | $4 | $14 | $24 |
| Lost growth on money paid in costs | $0 | $13 | $46 |
| Total costs | $83 | $273 | $498 |
| Value after costs | $10,417 | $11,303 | $12,265 |
| Impact on return, per year | 0.83% | 0.83% | 0.83% |
BGHBX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0422%
- Total broker commissions: $5K
- Bought from dealers (principal trades, not a cost): $175K
- Portfolio turnover (prospectus): 23%
- Securities lending: none during the year
BGHBX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $2K | 40.02% |
| JEFFERIES LLC | $512 | 10.78% |
| UBS Securities LLC | $506 | 10.66% |
| GOLDMAN SACHS & CO. LLC | $491 | 10.34% |
| INSTINET, LLC | $471 | 9.92% |
| BOFA SECURITIES, INC. | $203 | 4.28% |
| HSBC SECURITIES (USA) INC. | $200 | 4.21% |
| REDBURN (USA) LLC | $195 | 4.11% |
| MORGAN STANLEY & CO. LLC | $192 | 4.04% |
| Joh. Berenberg, Gossler & Co. KG | $78 | 1.64% |
BGHBX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS & CO. LLC | $174K | 99.20% |
| MORGAN STANLEY & CO. LLC | $1K | 0.80% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.